Metabolic disorder in Alzheimer's disease

Alzheimer's disease (AD), a well known aging-induced neurodegenerative disease is related to amyloid proteinopathy. This proteinopathy occurs due to abnormalities in protein folding, structure and thereby its function in cells. The root cause of such kind of proteinopathy and its related neurod...

Full description

Saved in:
Bibliographic Details
Published in:Metabolic brain disease 2021-06, Vol.36 (5), p.781-813
Main Authors: Poddar, Mrinal K, Banerjee, Soumyabrata, Chakraborty, Apala, Dutta, Debasmita
Format: Article
Language:English
Subjects:
Abnormalities
Age related diseases
Aging
Aging (artificial)
Alzheimer's disease
Amyloid
Epigenetics
Metabolic disorders
Metabolism
Metabolomics
Neurodegeneration
Neurodegenerative diseases
Neurotransmitters
Nutrients
Protein folding
Protein structure
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Alzheimer's disease (AD), a well known aging-induced neurodegenerative disease is related to amyloid proteinopathy. This proteinopathy occurs due to abnormalities in protein folding, structure and thereby its function in cells. The root cause of such kind of proteinopathy and its related neurodegeneration is a disorder in metabolism, rather metabolomics of the major as well as minor nutrients. Metabolomics is the most relevant "omics" platform that offers a great potential for the diagnosis and prognosis of neurodegenerative diseases as an individual's metabolome. In recent years, the research on such kinds of neurodegenerative diseases, especially aging-related disorders is broadened its scope towards metabolic function. Different neurotransmitter metabolisms are also involved with AD and its associated neurodegeneration. The genetic and epigenetic backgrounds are also noteworthy. In this review, the physiological changes of AD in relation to its corresponding biochemical, genetic and epigenetic involvements including its (AD) therapeutic aspects are discussed.
ISSN:0885-7490
1573-7365
1573-7365
DOI:10.1007/s11011-021-00673-z